UBC Reinforces Leadership In Biopharmacuetical Safety & Risk Mgmt. WIth Additon Of Gretchen Dieck

Tuesday, 09 February 2010

United BioSource Corporation (UBC) today announced that Dr. Gretchen Dieck has joined the company as Vice President, Safety, Epidemiology & Risk Management. Dr. Dieck is UBC’s latest addition to their roster of biopharmaceutical safety experts. Dr. Dieck joins UBC from Pfizer Inc, where she held positions of increasing responsibility for the last 23 years. Most recently, Dr. Dieck was Pfizer’s senior executive responsible for safety and risk management for the company’s entire portfolio of biopharmaceuticals. In this capacity, Dr Dieck led all aspects of biopharmaceutical safety and risk management, from initial human research through regulatory approval and marketing. ”We are very fortunate that Dr. Dieck has joined United BioSource Corporation,” said UBC Chief Executive Officer Ethan Leder. “Gretchen is a world-recognized leader in safety and risk management who brings a unique combination of strategic thinking and practical experience that is unparalleled in this industry. As the senior safety and risk management leader for the world’s largest biopharmaceutical company, Dr Dieck was responsible for managing a broad and diverse portfolio of products and provided significant input to the legislators who wrote many of the product safety requirements in the 2007 FDA Amendments Act. UBC clients will benefit significantly from the depth of experience and practical knowledge Gretchen brings to our company.” “I am extremely pleased to join the outstanding team at UBC. With leadership from experts such as Dr. Annette Stemhagen, UBC has built a position as the premier safety and risk management partner for the biopharmaceutical industry,” said Dr Dieck. “I look forward to helping the UBC team develop and implement effective safety and risk management strategies and programs that protect patients and address regulatory needs throughout the world.” Dr. Dieck joined Pfizer as an Assistant Director for Clinical Safety where she designed post-marketing surveillance studies. In her most recent role as Pfizer’s Senior Vice President, Safety & Risk Management, Dr. Dieck led the organization’s product safety functions, including pharmacovigilance, pharmacoepidemiology, risk management, and project management for all biopharmaceuticals beginning in first-in-human research through the entire product lifecycle. Dr. Dieck received her M. Phil and Ph.D. from Yale University where she also held a Postdoctoral Fellowship in Epidemiology. She is a member of the American College of Epidemiology, the Society for Epidemiologic Research, the International Society for Pharmacoepidemiology, and the American Public Health Association. Dr. Dieck is a Founding Member of the International Society for Pharmacoepidemiology and served as an Assistant Adjunct Professor of Public Health at Columbia University’s School of Public Health. About UBC UBC is a global medical and scientific affairs organization that partners with manufacturers of biopharmaceuticals and medical devices to develop and commercialize their products. UBC helps clients deliver authoritative, real-world evidence of product effectiveness, safety, and value. UBC brings together recognized scientific and industry experts, research operations professionals, and leading-edge technologies to provide clients with innovative solutions across the product lifecycle. The company is headquartered in Bethesda, Maryland, with offices in North and South America, Europe and Asia. For more information about UBC, visit www.unitedbiosource.com.